InnoCare is an emerging innovative drugs platform, poised to become China’s best chemical drug company covering immunology, I-O1 and oncology with sustainable innovative culture and seasoned team from global pharmaceutical companies.
InnoCare's BTK inhibitors outperform both domestic and foreign competitors in terms of safety and patient compliance (only one dosage a day), with potential to be best-in-class and clear path to regulatory approval in China around 2020.
Its R progress in FGFR4 inhibitors ranks first in China.
Location: China, Beijing
Employees: 51-200
Total raised: $55M
Founded date: 2013
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.02.2018 | - | $55M | Vivo Capit... |
Mentions in press and media 27
| Date | Title | Description | Source |
| 14.07.2023 | InnoCare and ArriVent Announce Clinical Development Collabor... | Companies will collaborate on investigating a novel SHP2 inhibitor in combination with furmonertinib... | einpresswi... |
| 23.03.2022 | InnoCare Releases 2021 Annual Results and Business Highlight... | BEIJING, March 23, 2022 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical c... | en.prnasia... |
| 14.03.2022 | InnoCare Announces Acceptance of Supplemental New Drug Appli... | BEIJING, March 14, 2022 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical c... | en.prnasia... |
| 02.03.2022 | InnoCare Announces Approval of Phase II Clinical Trial Using... | BEIJING, March 2, 2022 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical co... | en.prnasia... |
| 22.02.2022 | InnoCare Announces Dosing of First Patient in Phase II Clini... | BEIJING, Feb. 22, 2022 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical co... | en.prnasia... |
| 18.01.2022 | InnoCare and Keymed Jointly Announce Dosing of First Patient... | BEIJING, Jan. 18, 2022 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969) and Keymed Biosciences (HKEX: 0... | en.prnasia... |
| 07.01.2022 | InnoCare to Attend Upcoming Investor Conferences to Share La... | BEIJING, Jan. 7, 2022 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a leading biotech company, anno... | en.prnasia... |
| 14.12.2021 | Orelabrutinib Data Presented at the 63rd Annual Meeting of A... | BEIJING, Dec. 14, 2021 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a leading biotech company, ann... | en.prnasia... |
| 03.12.2021 | InnoCare Announces Inclusion of Orelabrutinib in China Natio... | BEIJING, Dec. 3, 2021 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a commercial-stage biotech comp... | en.prnasia... |
| 15.11.2021 | InnoCare Announces the Clearance of Clinical Trial of Novel ... | BEIJING, Nov. 15, 2021 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a commercial-stage biotech com... | en.prnasia... |
Show more